129 H. Macpherson et al., “Multivitamin-multimineral supplementation and mortality: a meta-analysis of randomized controlled trials.” American Journal of Clinical Nutrition 97, no. 2 (March 2013): 437–44.

130 H. D. Sesso et al., “Multivitamins in the prevention of cardiovascular disease in men: the Physicians’ Health Study II randomized controlled trial.” JAMA 308, no. 17 (November 2012): 1751–60.

131 D. H. Baker, “Cupric oxide should not be used as a copper supplement for either animals or humans.” Journal of Nutrition 129, no. 12 (December 1999): 2278–79.

132 G. S. Omenn, “Chemoprevention of lung cancer: the rise and demise of betacarotene.” Annual Review of Public Health 19 (January 1998): 73–99.

133 B. K. Dunn et al., “A nutrient approach to prostate cancer prevention: The Selenium and Vitamin E Cancer Prevention Trial (SELECT).” Nutrition and Cancer 62, no. 7 (January 2010): 896–918.

134 L. C. Clark et al., “Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.” JAMA 276, no. 24 (December 1996): 1957–63.

135 A. Vogiatzoglou et al., “Vitamin B₁₂ status and rate of brain volume loss in community-dwelling elderly.” Neurology 71, no. 11 (September 2008): 826–32.

136 G. Douaud et al., “Preventing Alzheimer’s disease-related gray matter atrophy by B-vitamin treatment.” Proceedings of the National Academy of Sciences of the United States of America 110, no. 23 (June 2013): 9523–28.

137 N. L. van der Zwaluw et al., “Results of 2-year vitamin B treatment on cognitive performance: secondary data from an RCT.” Neurology 83, no. 23 (December 2014): 2158–66.

138 J. G. Walker et al., “Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms – the Beyond Ageing Project: a randomized controlled trial.” American Journal of Clinical Nutrition 95, no. 1 (January 2012): 194–203.